Reimbursement rather than Brexit more likely to impact how drugmakers order...
The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.
View ArticleFive things for pharma marketers to know: Tuesday, September 6, 2016
MannKind plans to develop inhalable epinephrine; lawmakers accuse Mylan of evading paying higher Medicaid rebates; NICE rejects Roche's cancer drug
View ArticleReimbursement rather than Brexit more likely to impact how drugmakers order...
The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.
View ArticleFive things for pharma marketers to know: Tuesday, September 6, 2016
MannKind plans to develop inhalable epinephrine; lawmakers accuse Mylan of evading paying higher Medicaid rebates; NICE rejects Roche's cancer drug
View Article
More Pages to Explore .....
